UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity

Nature biotechnology, 2016-02, Vol.34 (2), p.155-163

2016

Volltextzugriff (PDF)

MBD-isolated Genome Sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome

Nucleic acids research, 2010-01, Vol.38 (2), p.391-399

2010

Volltextzugriff (PDF)

DNA Methylation Regulates Alternative Polyadenylation via CTCF and the Cohesin Complex

Molecular cell, 2020-05, Vol.78 (4), p.752-764.e6

2020

Volltextzugriff (PDF)

Functional Recovery After Partial Nephrectomy: Effects of Volume Loss and Ischemic Injury

The Journal of urology, 2012-05, Vol.187 (5), p.1667-1673

2012

Volltextzugriff (PDF)

Identification and functional analysis of epigenetically silenced microRNAs in colorectal cancer cells

PloS one, 2011-06, Vol.6 (6), p.e20628-e20628

2011

Volltextzugriff (PDF)

Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer

Nature genetics, 2016-04, Vol.48 (4), p.356-358

2016

Volltextzugriff (PDF)

Methylome-wide Sequencing Detects DNA Hypermethylation Distinguishing Indolent from Aggressive Prostate Cancer

Cell reports (Cambridge), 2015-12, Vol.13 (10), p.2135-2146

2015

Volltextzugriff (PDF)

Dysregulation of Cholesterol Homeostasis in Human Prostate Cancer through Loss of ABCA1

Cancer research (Chicago, Ill.), 2013-02, Vol.73 (3), p.1211-1218

2013

Volltextzugriff (PDF)

Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target

Clinical cancer research, 2019-01, Vol.25 (1), p.210-221

2019

Volltextzugriff (PDF)

Procainamide Is a Specific Inhibitor of DNA Methyltransferase 1

The Journal of biological chemistry, 2005-12, Vol.280 (49), p.40749-40756

2005

Volltextzugriff (PDF)

Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth

The Prostate, 2011-03, Vol.71 (4), p.333-343

2011

Volltextzugriff (PDF)

Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma

Human pathology, 2018-07, Vol.77, p.63-69

2018

Volltextzugriff (PDF)

Processing and cryopreservation of human ureter tissues for single-cell and spatial transcriptomics assays

STAR protocols, 2022-12, Vol.3 (4), p.101854-101854, Article 101854

2022

Volltextzugriff (PDF)

Real-Time Robotic Transrectal Ultrasound Navigation During Robotic Radical Prostatectomy: Initial Clinical Experience

Urology (Ridgewood, N.J.), 2012-09, Vol.80 (3), p.608-613

2012

Volltextzugriff (PDF)

5mC: what goes on must come off

Nature reviews. Molecular cell biology, 2022-05, Vol.23 (5), p.306-306

2022

Volltextzugriff (PDF)

A requirement for DICER to maintain full promoter CpG island hypermethylation in human cancer cells

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (8), p.2570-2575

2008

Volltextzugriff (PDF)

GSTP1 CpG Island Hypermethylation Is Responsible for the Absence of GSTP1 Expression in Human Prostate Cancer Cells

The American journal of pathology, 2001-11, Vol.159 (5), p.1815-1826

2001

Volltextzugriff (PDF)

Challenging the Paradigm of “BCG-unresponsive” Bladder Cancer: Does Additional Bacillus Calmette-Guérin Have an Effect?

European urology, 2024-10, Vol.86 (4), p.366-368

2024

Volltextzugriff (PDF)

Uretero-Enteric Anastomotic Stricture Following Radical Cystectomy: A Comparison of Open, Robotic Extracorporeal, and Robotic Intracorporeal Approaches

Urology (Ridgewood, N.J.), 2020-10, Vol.144, p.130-135

2020

Volltextzugriff (PDF)

Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors

Journal of clinical oncology, 2016-11, Vol.34 (33), p.4000-4007

2016

Volltextzugriff (PDF)

Commentary on: “Comprehensive transcriptional analysis of early-stage urothelial carcinoma.” Hedegaard J, Lamy P, Nordentoft I, Algaba F, Høyer S, Ulhøi BP, Vang S, Reinert T, Hermann GG, Mogensen K, Thomsen MB, Nielsen MM, Marquez M, Segersten U, Aine M, Höglund M, Birkenkamp-Demtröder K, Fristrup N, Borre M, Hartmann A, Stöhr R, Wach S, Keck B, Seitz AK, Nawroth R, Maurer T, Tulic C, Simic T, Junker K, Horstmann M, Harving N, Petersen AC, Calle ML, Steyerberg EW, Beukers W, van Kessel KE, Jens

Urologic oncology, 2017-09, Vol.35 (9), p.576-577

Lee, Byron H.

2017

Volltextzugriff (PDF)

Commentary on: "Comprehensive molecular characterization of papillary renal-cell carcinoma." Cancer Genome Atlas Research Network.: N Engl J Med. 2016 Jan 14;374(2):135-45

Urologic oncology, 2017-09, Vol.35 (9), p.578-579

Lee, Byron H

2017

Volltextzugriff (PDF)

Commentary on: “Inherited DNA-repair gene mutations in men with metastatic prostate cancer.” Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, S

Urologic oncology, 2017-09, Vol.35 (9), p.575-576

Lee, Byron H.

2017

Volltextzugriff (PDF)

Commentary on: “Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy.” Li Z, Alyamani M, Li J, Rogacki K, Abazeed M, Upadhyay SK, Balk SP, Taplin ME, Auchus RJ, Sharifi N. Nature. 2016 May 25;533(7604):547–51

Urologic oncology, 2017-09, Vol.35 (9), p.576-576

Lee, Byron H.

2017

Volltextzugriff (PDF)

Commentary on: "An integrated metabolic atlas of clear cell renal cell carcinoma." Hakimi AA, Reznik E, Lee CH, Creighton CJ, Brannon AR, Luna A, Aksoy BA, Liu EM, Shen R, Lee W, Chen Y, Stirdivant SM, Russo P, Chen YB, Tickoo SK, Reuter VE, Cheng EH, Sander C, Hsieh JJ.: Cancer Cell. 2016 Jan 11;29(1):104-16

Urologic oncology, 2017-09, Vol.35 (9), p.579-580

Lee, Byron H

2017

Volltextzugriff (PDF)

1 – 25 von 383

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(360)
Mit Volltextzugriff
(328)

Publikationsform

Sprache

Englisch
(380)
Japanisch
(54)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity

MBD-isolated Genome Sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome

DNA Methylation Regulates Alternative Polyadenylation via CTCF and the Cohesin Complex

Functional Recovery After Partial Nephrectomy: Effects of Volume Loss and Ischemic Injury

Identification and functional analysis of epigenetically silenced microRNAs in colorectal cancer cells

Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer

Methylome-wide Sequencing Detects DNA Hypermethylation Distinguishing Indolent from Aggressive Prostate Cancer

Dysregulation of Cholesterol Homeostasis in Human Prostate Cancer through Loss of ABCA1

Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target

Procainamide Is a Specific Inhibitor of DNA Methyltransferase 1

Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth

Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma

Processing and cryopreservation of human ureter tissues for single-cell and spatial transcriptomics assays

Real-Time Robotic Transrectal Ultrasound Navigation During Robotic Radical Prostatectomy: Initial Clinical Experience

5mC: what goes on must come off

A requirement for DICER to maintain full promoter CpG island hypermethylation in human cancer cells

GSTP1 CpG Island Hypermethylation Is Responsible for the Absence of GSTP1 Expression in Human Prostate Cancer Cells

Challenging the Paradigm of “BCG-unresponsive” Bladder Cancer: Does Additional Bacillus Calmette-Guérin Have an Effect?

Uretero-Enteric Anastomotic Stricture Following Radical Cystectomy: A Comparison of Open, Robotic Extracorporeal, and Robotic Intracorporeal Approaches

Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors

Commentary on: "Comprehensive molecular characterization of papillary renal-cell carcinoma." Cancer Genome Atlas Research Network.: N Engl J Med. 2016 Jan 14;374(2):135-45

Commentary on: “Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy.” Li Z, Alyamani M, Li J, Rogacki K, Abazeed M, Upadhyay SK, Balk SP, Taplin ME, Auchus RJ, Sharifi N. Nature. 2016 May 25;533(7604):547–51

Suchergebnisse filtern